321 related articles for article (PubMed ID: 30477309)
1. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
[TBL] [Abstract][Full Text] [Related]
2. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.
Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK
Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488
[TBL] [Abstract][Full Text] [Related]
4. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.
Sher MR; Steven GC; Romett JL; Pien G; LeBenger K; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
Rhinology; 2020 Feb; 58(1):25-35. PubMed ID: 31815255
[TBL] [Abstract][Full Text] [Related]
5. The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps.
Ow RA; McGinnis JP; Sacks HJ; Mehle ME
Ear Nose Throat J; 2022 Apr; ():1455613221088698. PubMed ID: 35437059
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014
[TBL] [Abstract][Full Text] [Related]
7. Effects of Fluticasone Exhalation Delivery System in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Wu D; Huang T; Wei Y
Am J Rhinol Allergy; 2022 Mar; 36(2):176-184. PubMed ID: 34342516
[TBL] [Abstract][Full Text] [Related]
8. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis.
Palmer JN; Jacobson KW; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
Int Forum Allergy Rhinol; 2018 Jun; 8(8):869-76. PubMed ID: 29856520
[TBL] [Abstract][Full Text] [Related]
9. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis?
Kovacs AJ; Goshtasbi K; Kuan EC
Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927
[TBL] [Abstract][Full Text] [Related]
10. Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
[TBL] [Abstract][Full Text] [Related]
11. Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
Kovacs AJ; Adappa ND; Kuan EC
Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays.
Senior BA; Schlosser RJ; Bosso J; Soler ZM
Int Forum Allergy Rhinol; 2021 May; 11(5):837-845. PubMed ID: 32970395
[TBL] [Abstract][Full Text] [Related]
13. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone.
Skoner DP; Meltzer EO; Skoner J; Sacks HJ; Lumry WR
Allergy Asthma Proc; 2022 Jan; 43(1):70-77. PubMed ID: 34753535
[No Abstract] [Full Text] [Related]
18. Short-course oral steroids alone for chronic rhinosinusitis.
Head K; Chong LY; Hopkins C; Philpott C; Burton MJ; Schilder AG
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011991. PubMed ID: 27113367
[TBL] [Abstract][Full Text] [Related]
19. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
20. Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
Soler ZM; Colman S; Velez FF; Schlosser RJ
Int Forum Allergy Rhinol; 2020 Jul; 10(7):848-855. PubMed ID: 32445277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
